CR7623A -
USE OF METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AS A MEANS OF CONTRAST IN MAGNETIC RESONANCE IMAGES TO REPRESENT INTRAVASAL THROMBES
- Google Patents
USE OF METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AS A MEANS OF CONTRAST IN MAGNETIC RESONANCE IMAGES TO REPRESENT INTRAVASAL THROMBES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AgfiledCriticalSchering Ag
Priority to CR7623ApriorityCriticalpatent/CR7623A/en
Publication of CR7623ApublicationCriticalpatent/CR7623A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Magnetic Resonance Imaging Apparatus
(AREA)
Abstract
Uso de complejos metalicos con contenido de perfluoroalquilo que presentan una concentracion de formacion de micelas critica 1nm y una relajacion de protones en plasma de (R1) > 10 l/mmol.s, como medio de contraste en las imagenes de resonancia magnetica para representar trombos intravasales.Use of metal complexes with perfluoroalkyl content that have a concentration of 1nm critical micelle formation and a plasma proton relaxation of (R1)> 10 l / mmol.s, as a contrast medium in magnetic resonance imaging to represent thrombi intravars.
CR7623A2004-12-152004-12-15
USE OF METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AS A MEANS OF CONTRAST IN MAGNETIC RESONANCE IMAGES TO REPRESENT INTRAVASAL THROMBES
CR7623A
(en)